Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03018405
Title A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celyad Oncology SA
Indications

ovary epithelial cancer

colorectal cancer

triple-receptor negative breast cancer

transitional cell carcinoma

multiple myeloma

acute myeloid leukemia

pancreatic cancer

fallopian tube carcinoma

myelodysplastic syndrome

Therapies

NKR-2 cells

Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
Recruiting Tampa Florida 33612 United States Details
Recruiting Buffalo New York 14263 United States Details
Recruiting Brussels 1200 Belgium Details
Recruiting Brussels Belgium Details
Recruiting Ghent Belgium Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field